FDA Approves Second Drug to Slow Alzheimer's Disease
Favicon 
www.newsmax.com

FDA Approves Second Drug to Slow Alzheimer's Disease

U.S. officials have approved another Alzheimer's drug that can modestly slow the disease, providing a new option for patients in the early stages of the incurable, memory-destroying ailment. The Food and Drug Administration approved Eli Lilly's Kisunla on Tuesday for mild or...